Literature DB >> 7592739

The primary structure of a basic leucine-rich repeat protein, PRELP, found in connective tissues.

E Bengtsson1, P J Neame, D Heinegård, Y Sommarin.   

Abstract

We have determined the primary structure of a connective tissue matrix protein from the nucleotide sequence of a clone isolated from a human articular chondrocyte cDNA library. The major part of the amino acid sequence has also been determined by direct protein sequencing. The translated primary sequence corresponds to 382 amino acid residues, including a 20-residue signal peptide. The molecular mass of the mature protein is 41,646 Da. The main part of the protein consists of 10 leucine-rich repeats ranging in length from 20 to 26 residues, with asparagine at position 10 (B-type). The N-terminal part is unusual in that it is basic and rich in arginine and proline. There are four potential N-linked glycosylation sites present. In three of these sites, post-translational modifications are likely to be present since Asn was not found by direct protein sequencing. The amino- and carboxyl-terminal parts contain four and two cysteine residues, respectively, probably forming disulfide bonds by analogy with the other members of this family. The protein shows highest identity (36%) to fibromodulin and 33% to bovine lumican, two other leucine-rich repeat connective tissue proteins. Northern blot analysis showed the presence of an approximately 3.8-kilobase mRNA in different types of bovine cartilage and cultured osteoblasts, whereas RNAs isolated from bovine kidney, skin, spleen, thymus, and trabecular bone and rat calvaria were negative. Human articular chondrocyte and rat chondrosarcoma cell RNAs contained an additional mRNA of approximately 1.6 and 1.8 kilobases, respectively.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592739     DOI: 10.1074/jbc.270.43.25639

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Genomic characterization of human DSPG3.

Authors:  M Deere; J L Dieguez; S J Yoon; D Hewett-Emmett; A de la Chapelle; J T Hecht
Journal:  Genome Res       Date:  1999-05       Impact factor: 9.043

2.  The Tyrosine Sulfate Domain of Fibromodulin Binds Collagen and Enhances Fibril Formation.

Authors:  Viveka Tillgren; Matthias Mörgelin; Patrik Önnerfjord; Sebastian Kalamajski; Anders Aspberg
Journal:  J Biol Chem       Date:  2016-09-15       Impact factor: 5.157

Review 3.  Fell-Muir Lecture: Proteoglycans and more--from molecules to biology.

Authors:  Dick Heinegård
Journal:  Int J Exp Pathol       Date:  2009-12       Impact factor: 1.925

4.  Cloning and chromosomal localization of mouse keratocan, a corneal keratan sulfate proteoglycan.

Authors:  J R Dunlevy; S Chakravarti; P Gyalzen; J P Vergnes; J R Hassell
Journal:  Mamm Genome       Date:  1998-04       Impact factor: 2.957

5.  Proteoglycans in Normal and Healing Skin.

Authors:  Margaret Mary Smith; James Melrose
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

6.  PRELP protein inhibits the formation of the complement membrane attack complex.

Authors:  Kaisa E Happonen; Camilla Melin Fürst; Tore Saxne; Dick Heinegård; Anna M Blom
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

Review 7.  The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis.

Authors:  A Hultgårdh-Nilsson; J Borén; S Chakravarti
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

Review 8.  Roles of lumican and keratocan on corneal transparency.

Authors:  Winston W-Y Kao; Chia-Yang Liu
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

9.  Phenotypic characterization of epiphycan-deficient and epiphycan/biglycan double-deficient mice.

Authors:  S Nuka; W Zhou; S P Henry; C M Gendron; J B Schultz; T Shinomura; J Johnson; Y Wang; D R Keene; R Ramírez-Solis; R R Behringer; M F Young; M Höök
Journal:  Osteoarthritis Cartilage       Date:  2009-11-18       Impact factor: 6.576

10.  The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis.

Authors:  Nadia Rucci; Anna Rufo; Marina Alamanou; Mattia Capulli; Andrea Del Fattore; Emma Ahrman; Daria Capece; Valeria Iansante; Francesca Zazzeroni; Edoardo Alesse; Dick Heinegård; Anna Teti
Journal:  J Cell Biol       Date:  2009-11-30       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.